Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack
2021 · Scientific Reports · 33 citations
https://doi.org/10.1038/s41598-021-86824-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
654
Citations
13
h-index
13
i10-index
De Cai is an academic researcher from Beijing Institute of Technology. The author has contributed to research in topics: Cancer-related Molecular Pathways & Cancer Research and Treatments & MicroRNA in disease regulation. The author has an h-index of 13, co-authored 34 publications.
ORCID: 0000-0002-9568-5318Click to start Chat